24/7 Market News Snapshot 29 April, 2025 – iBio, Inc. Common Stock (NASDAQ:IBIO)

April 29, 2025

DENVER, Colo., 29 April, 2025 (www.247marketnews.com) – (Nasdaq:IBIO) are discussed in this article.
iBio, Inc. (Nasdaq:IBIO), a leader in precision antibody therapies powered by artificial intelligence, is currently experiencing significant trading momentum. Opening at $1.06 and climbing to $1.179, the stock has seen an impressive increase of approximately 12.29% from the previous close of $1.050. The robust trading volume of 12.74 million shares indicates heightened investor interest and confidence, with the stock surpassing previous resistance levels. Analysts are monitoring support at the $1.06 mark, with potential for further upward movement should the bullish sentiment persist.

In a strategic move to strengthen its financial position, iBio has announced a successful warrant inducement transaction with several institutional investors. This initiative is set to generate approximately $6.2 million in gross proceeds, which will support general corporate activities and working capital needs. As part of the agreement, investors will exercise warrants for 5,626,685 shares of common stock at a reduced price of $1.11 per share. In exchange, they will receive new warrants allowing the purchase of an additional 11,253,370 shares at an attractive exercise price of $0.86. The new warrants will be valid for five years from the issuance date, enhancing investor engagement and flexibility.

Chardan has been appointed as the exclusive financial advisor for this transaction, which is expected to close around April 30, 2025, subject to customary conditions. Importantly, the securities linked to this transaction remain unregistered under applicable securities laws and will adhere to specific resale restrictions. iBio’s dedication to advancing biopharmaceutical development highlights its commitment to addressing significant health challenges, as it continues to innovate in the biopharmaceutical landscape.

Related news for (IBIO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.